Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral melatonin for nocturia in adults with Parkinson's disease (phase IIb pilot)
2014-002697-37Phase 2Completed
- Sponsor
- University College London
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of melatonin in Parkinson's disease (PD) and nocturia, sponsored by University College London. Primary endpoint: Primary: Improvement in nocturia-related bother. Started Mar 2015; status: completed.
02
Drugs
melatonin
03
Conditions
Parkinson's disease (PD)nocturia
Beyond the preview
Go deeper on 2014-002697-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-002697-37.